Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

A case of bizarre posttransplant anti-glomerular basement membrane disease.

Olewicz-Gawlik A, Żeromski J, Świerczewska M, Idasiak-Piechocka I, Pawlik M, Sikorska D, Samara H, Oko A, Sikora J, Dworacki G.

Cent Eur J Immunol. 2019;44(2):210-213. doi: 10.5114/ceji.2019.87074. Epub 2019 Jul 30.

2.

High frequency of macrophages expressing elevated level of CD80, PD-Ls and TLR1 in nasal polyps of CRS patients.

Kaczmarek M, Banaszewski J, Leszczyńska M, Łagiedo-Żelazowska M, Nowicka A, Romańska A, Wierzbicka M, Dworacki G.

Immunobiology. 2019 Jan;224(1):154-162. doi: 10.1016/j.imbio.2018.09.004. Epub 2018 Oct 21.

PMID:
30528981
3.

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.

Lange A, Jaskula E, Lange J, Dworacki G, Nowak D, Simiczyjew A, Mordak-Domagala M, Sedzimirska M.

PLoS One. 2018 Dec 6;13(12):e0209108. doi: 10.1371/journal.pone.0209108. eCollection 2018.

4.

The impact of dapagliflozin on glucose excursions related to early proatherogenic derangement in the aortic wall.

Stelmaszyk A, Wesołowska A, Pomieczyńska K, Iskakova S, Frydrychowicz M, Dworacki G, Dworacka M.

Saudi Pharm J. 2018 Dec;26(8):1192-1198. doi: 10.1016/j.jsps.2018.07.008. Epub 2018 Jul 20.

5.

Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability.

Dworacka M, Iskakova S, Wesołowska A, Zharmakhanova G, Stelmaszyk A, Frycz BA, Jagodziński PP, Dworacki G.

Diabetes Res Clin Pract. 2018 Sep;143:245-253. doi: 10.1016/j.diabres.2018.07.023. Epub 2018 Jul 26.

PMID:
30056191
6.

Relationship between the von Willebrand Factor Plasma Concentration and Ultrasonographic Doppler Findings in Pregnancies Complicated by Hypertensive Disorders: A Pilot Study.

Szpera-Gozdziewicz A, Gozdziewicz T, Boruczkowski M, Dworacki G, Breborowicz GH.

Gynecol Obstet Invest. 2018;83(3):252-258. doi: 10.1159/000488290. Epub 2018 Apr 5.

PMID:
29621786
7.

Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.

Borowczyk M, Janicki A, Dworacki G, Szczepanek-Parulska E, Danieluk M, Barnett J, Antonik M, Kałużna M, Bromińska B, Czepczyński R, Bączyk M, Ziemnicka K, Ruchała M.

J Endocrinol Invest. 2019 Jan;42(1):45-52. doi: 10.1007/s40618-018-0882-4. Epub 2018 Apr 4.

8.

New arguments for beneficial effects of alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes.

Dworacka M, Chukanova G, Iskakova S, Kurmambayev Y, Wesołowska A, Frycz BA, Jagodziński PP, Dworacki G.

Eur J Pharm Sci. 2018 May 30;117:41-47. doi: 10.1016/j.ejps.2018.02.009. Epub 2018 Feb 7.

PMID:
29427700
9.

The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.

Lange A, Jaskula E, Lange J, Dworacki G, Nowak D, Simiczyjew A, Mordak-Domagala M, Sedzimirska M.

PLoS One. 2018 Jan 5;13(1):e0190525. doi: 10.1371/journal.pone.0190525. eCollection 2018. Erratum in: PLoS One. 2018 Dec 6;13(12):e0209108.

10.

The Dual Role of Treg in Cancer.

Frydrychowicz M, Boruczkowski M, Kolecka-Bednarczyk A, Dworacki G.

Scand J Immunol. 2017 Dec;86(6):436-443. doi: 10.1111/sji.12615. Review.

12.

[Ibrutinib - new tool in hematologist hand, new challenges for internist].

Majcherek M, Dworacka M, Dworacki G.

Wiad Lek. 2017;70(1):92-95. Review. Polish.

PMID:
28343201
13.

pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms.

Wiśniewska-Chudy E, Szylberg Ł, Dworacki G, Mizera-Nyczak E, Marszałek A.

Oncol Rep. 2017 Apr;37(4):2295-2307. doi: 10.3892/or.2017.5476. Epub 2017 Feb 24.

PMID:
28260027
14.

Circulating endothelial cells, circulating endothelial progenitor cells, and von Willebrand factor in pregnancies complicated by hypertensive disorders.

Szpera-Goździewicz A, Majcherek M, Boruczkowski M, Goździewicz T, Dworacki G, Wicherek L, Bręborowicz GH.

Am J Reprod Immunol. 2017 Mar;77(3). doi: 10.1111/aji.12625.

PMID:
28224722
15.

Pituitary Microsomal Autoantibodies in Patients with Childhood-Onset Combined Pituitary Hormone Deficiency: an Antigen Identification Attempt.

Ziemnicka K, Gut P, Gołąb M, Dworacki G, Wrotkowska E, Stajgis M, Katulska K, Rabska-Pietrzak B, Obara-Moszyńska M, Niedziela M, Budny B, Kałużna M, Waśko R, Ruchała M.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(6):485-495. Epub 2016 Mar 12.

16.

Diagnosis, treatment, and prognosis in patients with liver metastases from follicular thyroid carcinoma (FTC).

Kałużna M, Gołąb M, Czepczyński R, Dworacki G, Bręborowicz D, Orłowski M, Katulska K, Klimowicz A, Gryczyńska M, Ruchała M, Ziemnicka K.

Endokrynol Pol. 2016;67(3):332-47. doi: 10.5603/EP.a2016.0040. Epub 2016 Feb 17.

17.

The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion.

Borowska M, Dworacka M, Wesołowska A, Winiarska H, Krzyżagórska E, Dworacki G.

Pharmacology. 2016;97(3-4):189-94. doi: 10.1159/000443897. Epub 2016 Feb 9.

PMID:
26854669
18.

Patterns of glomerular disease based on 4-year kidney biopsy material analyzed by light microscopy and immunofluorescence: a retrospective single-center analysis in Poland.

Olewicz-Gawlik A, Sikorska D, Pluto-Prądzyńska A, Roszak M, Idasiak-Piechocka I, Pawlaczyk K, Oko A, Woźniak A, Iwanik K, Dworacki G, Sikora J, Żeromski J.

Pol J Pathol. 2016;67(4):364-369. doi: 10.5114/pjp.2016.65870.

19.

Thymic emigration patterns in patients with type 2 diabetes treated with metformin.

Dworacki G, Urazayev O, Bekmukhambetov Y, Iskakova S, Frycz BA, Jagodziński PP, Dworacka M.

Immunology. 2015 Nov;146(3):456-69. doi: 10.1111/imm.12522. Epub 2015 Oct 5.

20.

[THE DIFFERENCES OF TREC (T-CELL RECEPTOR EXCISION CIRCLES) CONCENTRATION IN TYPE 2 DIABETIC PATIENTS].

Iskakova S, Urazayev O, Bekmukhambetov Y, Dworacki G, Dworacka M.

Georgian Med News. 2015 Jul-Aug;(244-245):29-36. Russian.

PMID:
26177132
21.

[Simvastatin's effect on insulin resistance in rats with diabetes mellitus].

Iskakova S, Zharmakhanova G, Bekmukhambetov Y, Dworacka M, Dworacki G.

Georgian Med News. 2015 May;(242):70-7. Russian.

PMID:
26042451
22.

Impaired Antigen-Specific Immune Response to Vaccines in Children with Antibody Production Defects.

Szczawinska-Poplonyk A, Breborowicz A, Samara H, Ossowska L, Dworacki G.

Clin Vaccine Immunol. 2015 Aug;22(8):875-82. doi: 10.1128/CVI.00148-15. Epub 2015 May 27.

23.

Alpha-lipoic acid modifies circulating angiogenic factors in patients with type 2 diabetes mellitus.

Dworacka M, Iskakova S, Krzyżagórska E, Wesołowska A, Kurmambayev Y, Dworacki G.

Diabetes Res Clin Pract. 2015 Feb;107(2):273-9. doi: 10.1016/j.diabres.2014.11.005. Epub 2014 Dec 3.

PMID:
25511715
24.

Increased circulating RANTES in type 2 diabetes.

Dworacka M, Krzyżagórska E, Iskakova S, Bekmukhambetov Y, Urazayev O, Dworacki G.

Eur Cytokine Netw. 2014 Jul-Sep;25(3):46-51. doi: 10.1684/ecn.2014.0355.

25.

Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer.

Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M, Yasar S, Dworacki G.

Scand J Immunol. 2015 Jan;81(1):2-10. doi: 10.1111/sji.12247. Review.

26.

Circulating monocyte chemotactic protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1) and angiogenin in type 2 diabetic patients treated with statins in low doses.

Dworacka M, Krzyżagórska E, Wesołowska A, Zharmakhanova G, Iskakova S, Dworacki G.

Eur J Pharmacol. 2014 Oct 5;740:474-9. doi: 10.1016/j.ejphar.2014.06.041. Epub 2014 Jun 30.

PMID:
24991787
27.

Circulating CD3+56+ cell subset in pre-diabetes.

Dworacka M, Wesołowska A, Wysocka E, Winiarska H, Iskakova S, Dworacki G.

Exp Clin Endocrinol Diabetes. 2014 Feb;122(2):65-70. doi: 10.1055/s-0033-1363233. Epub 2014 Feb 19.

PMID:
24554505
28.

Statins in low doses reduce VEGF and bFGF serum levels in patients with type 2 diabetes mellitus.

Dworacka M, Krzyżagórska E, Wesołowska A, Borowska M, Iskakova S, Dworacki G.

Pharmacology. 2014;93(1-2):32-8. doi: 10.1159/000357476. Epub 2014 Jan 10.

PMID:
24434301
29.

In vitro reconstruction of inflammatory reaction in human semen: effect on sperm DNA fragmentation.

Fraczek M, Szumala-Kakol A, Dworacki G, Sanocka D, Kurpisz M.

J Reprod Immunol. 2013 Nov;100(1):76-85.

30.

PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.

Szczepanski MJ, DeLeo AB, Łuczak M, Molinska-Glura M, Misiak J, Szarzynska B, Dworacki G, Zagor M, Rozwadowska N, Kurpisz M, Krzeski A, Kruk-Zagajewska A, Kopec T, Banaszewski J, Whiteside TL.

Oral Oncol. 2013 Feb;49(2):144-51. doi: 10.1016/j.oraloncology.2012.08.005. Epub 2012 Sep 1.

31.

Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.

Harasymczuk M, Gooding W, Kruk-Zagajewska A, Wojtowicz J, Dworacki G, Tomczak H, Szyfter W, Whiteside TL.

Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1105-14. doi: 10.1007/s00405-012-2117-1. Epub 2012 Aug 4.

32.

A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

Saucedo-Zeni N, Mewes S, Niestroj R, Gasiorowski L, Murawa D, Nowaczyk P, Tomasi T, Weber E, Dworacki G, Morgenthaler NG, Jansen H, Propping C, Sterzynska K, Dyszkiewicz W, Zabel M, Kiechle M, Reuning U, Schmitt M, Lücke K.

Int J Oncol. 2012 Oct;41(4):1241-50. doi: 10.3892/ijo.2012.1557. Epub 2012 Jul 16.

33.

Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients.

Lukasik M, Michalak S, Dworacki G, Siewiera K, Kaczmarek M, Watala C, Kozubski W.

Thromb Haemost. 2012 Jul;108(1):107-18. doi: 10.1160/TH11-12-0860. Epub 2012 May 25.

PMID:
22627503
34.

Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.

Lukasik M, Dworacki G, Kufel-Grabowska J, Watala C, Kozubski W.

Thromb Haemost. 2012 Feb;107(2):346-55. doi: 10.1160/TH11-05-0345. Epub 2012 Jan 11.

PMID:
22234746
35.

Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients.

Lukasik M, Dworacki G, Michalak S, Kufel-Grabowska J, Golanski J, Watala C, Kozubski W.

Thromb Res. 2011 Nov;128(5):e73-80. doi: 10.1016/j.thromres.2011.06.016. Epub 2011 Jul 23.

PMID:
21788065
36.

Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke.

Lukasik M, Dworacki G, Michalak S, Kufel-Grabowska J, Watala C, Kozubski W.

Platelets. 2012;23(2):132-42. doi: 10.3109/09537104.2011.597528. Epub 2011 Jul 19.

PMID:
21767237
37.

The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man.

Mozer-Lisewska I, Sikora J, Kowala-Piaskowska A, Kaczmarek M, Dworacki G, Zeromski J.

Arch Immunol Ther Exp (Warsz). 2010 Aug;58(4):295-302. doi: 10.1007/s00005-010-0087-9. Epub 2010 Jun 10. Review.

PMID:
20533094
38.

Can the condition of the cell microenvironment of mediastinal lymph nodes help predict the risk of metastases in non-small cell lung cancer?

Zieliński P, Dyszkiewicz W, Piwkowski CT, Dworacki G, Gasiorowski L.

Cancer Epidemiol. 2009 Nov;33(5):387-90. doi: 10.1016/j.canep.2009.10.011. Epub 2009 Nov 20.

PMID:
19931500
39.

Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium.

Ksiazek K, Mikuła-Pietrasik J, Catar R, Dworacki G, Winckiewicz M, Frydrychowicz M, Dragun D, Staniszewski R, Jörres A, Witowski J.

Int J Cancer. 2010 Jul 15;127(2):293-303. doi: 10.1002/ijc.25036.

40.

[Venous thromboembolism in a patient with noninvasive thymoma and a history of pemphigus].

Elikowski W, Dyszkiewicz W, Małek M, Karman K, Kasprzyk M, Dworacki G, Stepień B.

Kardiol Pol. 2009 Sep;67(9):999-1003. Polish.

PMID:
19838957
41.

Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.

Hendrickson RC, Cicinnati VR, Albers A, Dworacki G, Gambotto A, Pagliano O, Tüting T, Mayordomo JI, Visus C, Appella E, Shabanowitz J, Hunt DF, DeLeo AB.

Cancer Immunol Immunother. 2010 Jan;59(1):113-24. doi: 10.1007/s00262-009-0730-7. Epub 2009 Jun 27.

42.

Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin.

Ksiazek K, Mikula-Pietrasik J, Korybalska K, Dworacki G, Jörres A, Witowski J.

Am J Pathol. 2009 Apr;174(4):1230-40. doi: 10.2353/ajpath.2009.080613. Epub 2009 Feb 26.

43.

[The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].

Czyz A, Dworacki G, Komarnicki M.

Postepy Hig Med Dosw (Online). 2008 Jul 23;62:354-63. Review. Polish.

44.

[Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl].

Szpecht D, Derwich K, Wachowiak J, Konatkowska B, Dworacki G.

Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1041-4. Polish.

PMID:
19531823
45.

[Expression of toll-like receptors on blood leucocytes of children with chronic viral hepatitis C].

Mozer-Lisewska I, Słuzewski W, Dworacki G, Kaczmarek M, Kowala-Piaskowska A, Figlerowicz M, Zeromski J.

Przegl Epidemiol. 2006;60(4):657-63. Polish.

PMID:
17682745
46.

Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.

Dworacka M, Winiarska H, Borowska M, Abramczyk M, Bobkiewicz-Kozlowska T, Dworacki G.

Circ J. 2007 Jun;71(6):962-7.

47.

Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma.

Cicinnati VR, Zhang X, Yu Z, Ferencik S, Schmitz KJ, Dworacki G, Kaczmarek E, Oldhafer K, Frilling A, Baba HA, Schmid KW, Grosse-Wilde H, Broelsch CE, DeLeo AB, Gerken G, Beckebaum S.

Int J Cancer. 2006 Dec 15;119(12):2851-60.

48.

[Primary hypoparathyroidism and hypergonadotropic hypogonadism in a male patient with common variable immunodeficiency. A case report].

Baszko-Błaszyk D, Dworacki G, Horst-Sikorska W, Sowiński J.

Pol Arch Med Wewn. 2005 Nov;114(5):1089-92. Polish.

PMID:
16789508
49.

Significance of alterations in PBMC immunophenotype of children with chronic viral hepatitis C-- the role of dendritic cells.

Mozer-Lisewska I, Dworacki G, Kaczmarek E, Sluzewski W, Kaczmarek M, Woźniak A, Zeromski J.

Scand J Immunol. 2006 Apr;63(4):311-9.

50.

[Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin].

Mozer-Lisewska I, Dworacki G, Kaczmarek E, Słuzewski W, Kowala-Piaskowska A, Figlerowicz M, Kaczmarek M, Zeromski J.

Przegl Epidemiol. 2005;59(2):483-9. Polish.

PMID:
16190557

Supplemental Content

Loading ...
Support Center